Error in Results - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to the Reported Analytic Sample Size in the Results

  • November 1, 2026

Share

Clinical Scorecard: Correction to the Reported Analytic Sample Size in the Results

At a Glance

CategoryDetail
ConditionStatin eligibility according to atherosclerotic cardiovascular disease risk in the US
Key MechanismsNot described in the correction notice.
Target PopulationThe analytic sample in the original investigation; the correction notice does not provide further population details.
Care SettingUS population-level analysis of statin eligibility; the correction notice does not specify a clinical care setting.

Key Highlights

  • The original investigation was published online on August 20, 2025, and subsequently in the October 2025 issue.
  • The analytic sample size reported in the results was corrected from 133.6 million to 113.6 million.
  • The article has been corrected online.

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          The correction notice identifies an analytic sample of 113.6 million but provides no additional patient characteristics.

          The notice concerns a correction to the reported sample size and provides no prescribing or treatment details.

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Related Content